New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F17%3A00477657" target="_blank" >RIV/61388963:_____/17:00477657 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1016/j.bmc.2017.06.046" target="_blank" >http://dx.doi.org/10.1016/j.bmc.2017.06.046</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.bmc.2017.06.046" target="_blank" >10.1016/j.bmc.2017.06.046</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity
Popis výsledku v původním jazyce
New 2,4-diamino-6-[2-(phosphonomethoxy) ethoxy] pyrimidine (PMEO-DAPy) and 1-[2-(phosphonomethoxy) ethyl]-5-azacytosine (PME-5-azaC) prodrugs were prepared with a pro-moiety consisting of carbonyloxymethyl esters (POM, POC), alkoxyalkyl esters, amino acid phosphoramidates and/or tyrosine. The activity of the prodrugs was evaluated in vitro against different virus families. None of the synthesized prodrugs demonstrated activity against RNA viruses but some of them proved active against herpesviruses [including herpes simplex virus (HSV), varicella-zoster virus (VZV), and human cytomegalovirus (HCMV)]. The bis(POC) and the bis(amino acid) phosphoramidate prodrugs of PMEO-DAPy inhibited herpesvirus replication at lower doses than the parent compound although the selectivity against HSV and VZV was only slightly improved compared to PMEO-DAPy. The mono-octadecyl ester of PME5- azaC emerged as the most potent and selective PME-5-azaC prodrug against HSV, VZV and HCMV with EC50's of 0.15-1.12 mM while PME-5-azaC only had marginal anti-herpesvirus activity. Although the bis (hexadecylamido-L-tyrosyl) and the bis(POM) esters of PME-5-azaC were also very potent anti-herpesvirus drugs, these were less selective than the mono-octadecyl ester prodrug.
Název v anglickém jazyce
New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity
Popis výsledku anglicky
New 2,4-diamino-6-[2-(phosphonomethoxy) ethoxy] pyrimidine (PMEO-DAPy) and 1-[2-(phosphonomethoxy) ethyl]-5-azacytosine (PME-5-azaC) prodrugs were prepared with a pro-moiety consisting of carbonyloxymethyl esters (POM, POC), alkoxyalkyl esters, amino acid phosphoramidates and/or tyrosine. The activity of the prodrugs was evaluated in vitro against different virus families. None of the synthesized prodrugs demonstrated activity against RNA viruses but some of them proved active against herpesviruses [including herpes simplex virus (HSV), varicella-zoster virus (VZV), and human cytomegalovirus (HCMV)]. The bis(POC) and the bis(amino acid) phosphoramidate prodrugs of PMEO-DAPy inhibited herpesvirus replication at lower doses than the parent compound although the selectivity against HSV and VZV was only slightly improved compared to PMEO-DAPy. The mono-octadecyl ester of PME5- azaC emerged as the most potent and selective PME-5-azaC prodrug against HSV, VZV and HCMV with EC50's of 0.15-1.12 mM while PME-5-azaC only had marginal anti-herpesvirus activity. Although the bis (hexadecylamido-L-tyrosyl) and the bis(POM) esters of PME-5-azaC were also very potent anti-herpesvirus drugs, these were less selective than the mono-octadecyl ester prodrug.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10401 - Organic chemistry
Návaznosti výsledku
Projekt
<a href="/cs/project/GA14-00522S" target="_blank" >GA14-00522S: Syntézy nových prolékových forem biologicky aktivních nukleotidových analogů</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Bioorganic & Medicinal Chemistry
ISSN
0968-0896
e-ISSN
—
Svazek periodika
25
Číslo periodika v rámci svazku
17
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
12
Strana od-do
4637-4648
Kód UT WoS článku
000407831300010
EID výsledku v databázi Scopus
2-s2.0-85026313573